OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

HTML

Year: 2011
Type: review
Source: Expert Opinion on Therapeutic Targets
DOI: 10.1517/14728222.2011.600691
Authors: Ann Mosegaard Bak, Lærke Egefjord, Michael Gejl, Charlotte Steffensen, Chalotte Willemann Stecher, Kamille Smidt, Birgitte Brock, Jørgen Rungby
Institutions: Aarhus University Hospital, Aarhus University
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: glucagon-like peptide-1, amyloid-beta, Alzheimer's disease, type 2 diabetes, GLP-1 receptor, GLP-1 receptor agonists, insulin signaling, neuroprotection, neurotrophic effects, synaptic function, cognitive function, learning and memory, drug repurposing
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1997581405
FWCI: 0.282
Cites: 89
Cited by: 37
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security